altaweb.eu

humunity.eu

HUMUNITY

http://www.humunity.eu/people.html

Cell-Based Models of Human Mucosal Immunity with Multiple Commercial Applications. Models with primary human cells that can mimic the physiological role of the mucosa of the upper respiratory tract during disease and health. Beyond research, I enjoy traveling, learning new languages and exploring new cultures in terms of food, music and dance. Besides my academic experience, I have been a member of IAESTE student organization and carried out a voluntary project at an orphan house in Nepal where I have ac...

humunity.eu

HUMUNITY

http://www.humunity.eu/publications.html

Cell-Based Models of Human Mucosal Immunity with Multiple Commercial Applications. Italiani, P. and D. Boraschi. 2014. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Toepfer, E., J. D. Gavigan-Imedio, M.P. Madej, G. Sipos, and D. Boraschi. 2014. Innate immune cells: key regulators of homeostasis and inflammation in gut and airway mucosae. Boraschi, D., and P. Italiani. 2014. Immunosenescence and vaccine failure in the elderly: strategies for improving response. The bio-...

humunity.eu

HUMUNITY

http://www.humunity.eu/partners.html

Cell-Based Models of Human Mucosal Immunity with Multiple Commercial Applications. Consiglio Nazionale delle Ricerche. CNR) - Coordinator,. Università degli Studi di Pisa. ALTA S.r.l.u.

abirisk.eu

ABIRISK

http://www.abirisk.eu/links.html

And analysis of clinical relevance to minimize the RISK. Innovative Medicine Iniziative (IMI). European Federation of Pharmaceutical Industries and Association (EFPIA). European Immunogenicity Platform (EIP). European Medicines Agency (EMA). US Food and Drug Administration (FDA).

abirisk.eu

ABIRISK

http://www.abirisk.eu/objectives.html

And analysis of clinical relevance to minimize the RISK. Access to large cohorts of patients treated with biopharmaceutical products (BPs). Analyses of the mechanisms and consequences of immunization against biopharmaceutical products. Require extensive post-marketing follow-up of patients, with comparisons of several BPs. And various clinical conditions treated with the same BP. Has been designed to meet all of these requirements in order to target three types of disorders:. For the study of anti-drug.

abirisk.eu

ABIRISK

http://www.abirisk.eu/project_organization.html

And analysis of clinical relevance to minimize the RISK. To achieve project objectives ABIRISK is organized in 5 Working Packages (WPs). Main relationship between ABIRISK WPs:. ADA assay development and validation and cohort management. UCB Pharma S.A. GlaxoSmithKline Research and Development Limited. Cellular characterization and mechanisms of the AD immune response. Sanofi-Aventis Research and Development. Evaluation and development of technologies for predicting immunogenicity.

abirisk.eu

ABIRISK

http://www.abirisk.eu/publications.html

And analysis of clinical relevance to minimize the RISK. Publications repository and other external communications. Cyprien Mbogning and Philippe Broët. Bagging survival tree procedure for variable selection and prediction in the presence of nonsusceptible patients. 2016 Jun 7;17(1):230. Open it on the web. Roni Weisshof, Bella Ungar, Alexandra Blatt, Aviva Dahan, Matti Waterman, Uri Kopylov, Shomron Ben-Horin and Yehuda Chowers, on behalf of the ABIRISK consortium. Open it on the web. Open it on the web.

immunoageing.eu

ImmunoAgeing

http://www.immunoageing.eu/participants.html

An integrated approach to dissect determinants, risk. Factors and pathways of. Ageing of the immune system. Consiglio Nazionale delle Ricerche Istituto di Ricerca Genetica e Biomedica. The Chancellor, Masters and Scholars. Of the University of Cambridge. ALTA Ricerche e Sviluppo in Biotecnologie S.r.l.u.

immunoageing.eu

ImmunoAgeing

http://www.immunoageing.eu/index.html

An integrated approach to dissect determinants, risk. Factors and pathways of. Ageing of the immune system. Changes occurring in the immune system of ageing humans (the ‘immunosenescence’) have huge consequences on health. But their exact nature and underlying mechanisms are still largely unknown. Some important manifestations of immunosenescence are evident as an increased susceptibility to infection, reduced responses to vaccination. And a persistent state of low-level inflammation. Cittadella Universi...

immunoageing.eu

ImmunoAgeing

http://www.immunoageing.eu/publications.html

An integrated approach to dissect determinants, risk. Factors and pathways of. Ageing of the immune system. Please come back to visit this page in the next few months.